Effects of enoxaparin and nadroparin on major cardiac events in high-risk unstable angina treated with a glycoprotein IIb/IIIa inhibitor.

Okmen, Ertan; Ozen, Ersin; Uyarel, Huseyin; Sanli, Arda; Tartan, Zeynep; Cam, Nese

Okmen, Ertan; Ozen, Ersin; Uyarel, Huseyin; Sanli, Arda; Tartan, Zeynep; Cam, Nese.

Affiliation

Okmen E; Department of Cardiology, Siyami Ersek Cardiovascular and Thoracic Surgery Center, Istanbul, Turkey.

Jpn Heart J ; 44(6): 899-906, 2003 Nov.

Article in En | MEDLINE | ID: mdl-14711185

Subject(s)

Angina, Unstable/drug therapy; Anticoagulants/administration & dosage; Enoxaparin/administration & dosage; Nadroparin/administration & dosage; Platelet Aggregation Inhibitors/administration & dosage; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors; Tyrosine/analogs & derivatives; Tyrosine/administration & dosage; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipidemias/complications; Hypertension/complications; Male; Middle Aged; Risk; Tirofiban; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tyrosine / Platelet Aggregation Inhibitors / Nadroparin / Enoxaparin / Platelet Glycoprotein GPIIb-IIIa Complex / Angina, Unstable / Anticoagulants Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Jpn Heart J Year: 2003 Document type: Article Affiliation country: Turkey Country of publication: Japan

Search on Google

Add to My VHL

XML

PubMed Links